7 studies were found.

1.		No longer recruiting	ABI-007 in Taxol Resistant Patients with Metastatic Breast Cancer Conditions: Breast Neoplasms; Metastases, Neoplasm
2.		Recruiting	A Safety Study of ABI-007 for In-Stent Restenosis Conditions: Angina Pectoris; Coronary Artery Disease
3.		Completed	Study of ABI-007 and Taxol in Patients with Metastatic Breast Cancer Conditions: Breast Neoplasms; Metastases, Neoplasm
4.		Recruiting	Study of ABI-007 in Combination with Carboplatin and Herceptin in Patients with Advanced Breast Cancer Condition: Breast Cancer
5.		Recruiting	Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients with Advanced Non-Small Cell Lung Cancer Condition: Non-small cell lung cancer
6.		No longer recruiting	A Trial of ABI-007 in Patients with Advanced Non-Hematologic Malignancies Conditions: Neoplasms; Metastases, Neoplasm
7.		Recruiting	Trial of ABI-007 in Previously Treated Patients with Metastatic Melanoma Conditions: Melanoma; Metastases